Cargando…
Gut metabolites predict Clostridioides difficile recurrence
BACKGROUND: Clostridioides difficile infection (CDI) is the most common hospital acquired infection in the USA, with recurrence rates > 15%. Although primary CDI has been extensively linked to gut microbial dysbiosis, less is known about the factors that promote or mitigate recurrence. Moreover,...
Autores principales: | Dawkins, Jennifer J., Allegretti, Jessica R., Gibson, Travis E., McClure, Emma, Delaney, Mary, Bry, Lynn, Gerber, Georg K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178838/ https://www.ncbi.nlm.nih.gov/pubmed/35681218 http://dx.doi.org/10.1186/s40168-022-01284-1 |
Ejemplares similares
-
Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
por: Aguirre, Andrea Martinez, et al.
Publicado: (2022) -
Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites
por: Martinez-Gili, Laura, et al.
Publicado: (2020) -
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures
por: Worley, Jay Noboru, et al.
Publicado: (2023) -
Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 2019
por: Allegretti, Jessica R, et al.
Publicado: (2021) -
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021)